Molecular diagnosis of non-deletion SMA patients using quantitative PCR of SMN exon 7 (original) (raw)

ABSTRACT

The telomeric survival motor neuron (SMNT gene is a valuable molecular diagnostic tool for childhood-onset spinal muscular atrophy (SMA) as homozygous deletions of SMNT exon 7 (Δ7SMNT) are present in ∼94% of patients. In this report, we provide the first comprehensive study of 32 unrelated non-deletion SMA patients. Quantitative polymerase chain reaction (PCR) studies established that 90% had two intact copies of SMNT exon 7 suggesting that that these patients do not have 5q SMA. Once 5q SMA is confirmed, the SMNT gene can be screened for subtle mutations. Using single strand conformation analysis, we identified two missense mutations (P245L and Y272C) in exon 6 of the SMNT gene of two SMA patients shown to have a single copy of SMNT exon 7. Y272 is most likely critical for SMNT function as it is target for recurring mutations and is associated with type I SMA. These results emphasize the need for dosage analysis in the differential diagnosis of 5q SMA in non-deletion patients, consistent with extensive clinical heterogeneity and some genetic heterogeneity in this disease. Homozygosity or heterozygosity for a Δ7SMNT allele confirms the diagnosis of 5q SMA with greater precision than clinical examination alone.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Department of Genetics, Hopital Sainte-Justine, Montréal, Québec, Canada, , , , , , CA
    C.F. Rochette & L.R. Simard
  2. Department of Genetics, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada, , , , , , CA
    L.C. Surh
  3. Department of Genetics, Hospital for Sick Children, Toronto, Ontario, Canada, , , , , , CA
    P.N. Ray
  4. Department of Pathology, The Ohio State University, Columbus, Ohio, USA, , , , , , US
    P.E. McAndrew & T.W. Prior
  5. Department of Neurology, The Ohio State University, Columbus, Ohio, USA, , , , , , US
    A.H.M. Burghes
  6. Department of Pediatrics, Hopital Sainte-Justine, Montréal, Québec, Canada, , , , , , CA
    M. Vanasse

Authors

  1. C.F. Rochette
    You can also search for this author inPubMed Google Scholar
  2. L.C. Surh
    You can also search for this author inPubMed Google Scholar
  3. P.N. Ray
    You can also search for this author inPubMed Google Scholar
  4. P.E. McAndrew
    You can also search for this author inPubMed Google Scholar
  5. T.W. Prior
    You can also search for this author inPubMed Google Scholar
  6. A.H.M. Burghes
    You can also search for this author inPubMed Google Scholar
  7. M. Vanasse
    You can also search for this author inPubMed Google Scholar
  8. L.R. Simard
    You can also search for this author inPubMed Google Scholar

Additional information

Received July 14, 1997; Revised and Accepted July 15, 1997

Rights and permissions

About this article

Cite this article

Rochette, C., Surh, L., Ray, P. et al. Molecular diagnosis of non-deletion SMA patients using quantitative PCR of SMN exon 7.Neurogenetics 1, 141–147 (1997). https://doi.org/10.1007/s100480050021

Download citation